info@laboratoriogenoma.eu | Contact center: +39 06 164 161 500

Oops...
Slider with alias en-header-onconext not found.

Non hai trovato l'analisi che cercavi?

Esegui una ricerca nel nostro database

TAT:

20

Tipo di Campione:

Metodica:

Analisi presente in:

OncoNext™ Risk – Oncoscreening Complete

OncoNext ™ Risk OncoScreening Complete is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to hereditary cancers, including: Breast Cancer, Ovarian / Uterus Cancer, Colorectal Cancer, Stomach Cancer, Pancreatic Cancer, Prostate Cancer, Skin Cancer (Melanoma), Brain Cancer, Kidney Cancer and Pheochromocytoma / Paraganglioma.
OncoNext ™ Risk OncoScreening Complete allows patients to know, through the analysis of their DNA, if they are predisposed to the development of a particular type of cancer. The test, therefore, allows to identify people at risk of developing a specific neoplasia.
 

Geni/Polimorfismi:

AIP, ALK, APC, ATM, BAP1, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CDC73, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, DICER1, EPCAM, EXT1, EXT2, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HNF1A, HOXB13, HRAS, KIT, MAX, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH6, MUTYH, NF1, NF2, NSD1, PALB2, PHOX2B, PMS1, PMS2, POLD1, PRF1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RET, RHBDF2, RUNX1, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TP53, TSC1, TSC2, WT1
Oops...
Slider with alias slider-Oncology not found.
Richiesta Informazioni

Se desideri ricevere informazioni compila i campi a fianco, ti contatteremo al più presto.

+39 06164161500

numero_verde